title: Biomedical warfare.
abstract: A bruising battle for scarce research dollars is being waged among competing advocacy groups that seek cures for dread diseases. Many activists are unwilling to leave decisions to the scientists. They want Congress to decide which diseases deserve the most bucks.
authors.forename: M W
authors.initials: MW
authors.lastname: Serafini
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000191:economics / Q000453:epidemiology; D000544:Alzheimer Disease / Q000191:economics / Q000453:epidemiology; D001943:Breast Neoplasms / Q000191:economics / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000191:economics / Q000453:epidemiology; D006292:Health Priorities; D006331:Heart Diseases / Q000191:economics / Q000453:epidemiology; D006801:Humans; D009316:National Institutes of Health (U.S.); D010300:Parkinson Disease / Q000191:economics / Q000453:epidemiology; D010344:Patient Advocacy / Q000331:legislation & jurisprudence*; D011057:Politics; D012109:Research Support as Topic / Q000331:legislation & jurisprudence*; D014481:United States / Q000453:epidemiology